中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
5期
29-30,31
,共3页
陈志锋%陈观杏%陈卓莲%莫光洲%梁松荣
陳誌鋒%陳觀杏%陳卓蓮%莫光洲%樑鬆榮
진지봉%진관행%진탁련%막광주%량송영
非典型病原体%混合感染%COPD
非典型病原體%混閤感染%COPD
비전형병원체%혼합감염%COPD
Atypical pathogens%Mixed infection%COPD
目的:研究与探讨在COPD患者中开展非典型致病菌混合感染的调查,积极实施治疗并作疗效评估的意义。方法:选用2012年7月-2014年4月入住本院治疗的COPD患者200例,随机分成两组。给予对照组患者常规治疗,治疗组患者在常规治疗的基础上,进行常规非典型致病菌混合感染的检查,并详细分析病原学检查结果。结果:调整抗感染方案前,治疗组治疗效果优于对照组(P<0.05),调整抗感染方案后,对照组治疗效果、死亡率与治疗组比较差异无统计学意义(P>0.05),调整抗感染方案后对照组治疗效果明显好于调整前(P<0.05)。结论:在COPD患者中开展非典型致病菌混合感染的调查,可以提升患者的治疗效果。
目的:研究與探討在COPD患者中開展非典型緻病菌混閤感染的調查,積極實施治療併作療效評估的意義。方法:選用2012年7月-2014年4月入住本院治療的COPD患者200例,隨機分成兩組。給予對照組患者常規治療,治療組患者在常規治療的基礎上,進行常規非典型緻病菌混閤感染的檢查,併詳細分析病原學檢查結果。結果:調整抗感染方案前,治療組治療效果優于對照組(P<0.05),調整抗感染方案後,對照組治療效果、死亡率與治療組比較差異無統計學意義(P>0.05),調整抗感染方案後對照組治療效果明顯好于調整前(P<0.05)。結論:在COPD患者中開展非典型緻病菌混閤感染的調查,可以提升患者的治療效果。
목적:연구여탐토재COPD환자중개전비전형치병균혼합감염적조사,적겁실시치료병작료효평고적의의。방법:선용2012년7월-2014년4월입주본원치료적COPD환자200례,수궤분성량조。급여대조조환자상규치료,치료조환자재상규치료적기출상,진행상규비전형치병균혼합감염적검사,병상세분석병원학검사결과。결과:조정항감염방안전,치료조치료효과우우대조조(P<0.05),조정항감염방안후,대조조치료효과、사망솔여치료조비교차이무통계학의의(P>0.05),조정항감염방안후대조조치료효과명현호우조정전(P<0.05)。결론:재COPD환자중개전비전형치병균혼합감염적조사,가이제승환자적치료효과。
Objective:To discuss and investigate the implementation of investigation of mixed infection of atypical pathogenic bacteria in patients with COPD ,and the significance of actively implement the treatment and efficacy evaluation.Method:200 patients with COPD in our hospital from July 2012 to April 2014 were selected,they were randomly divided into the control group and the treatment group,100 cases in each group.The control group was given conventional treatment.On the basis of conventional treatment,the treatment group was given routine examination of atypical pathogens mixed infection and the etiological examination results were analyzed in detail.Result:Before anti infection scheme adjustment,the treatment effect of treatment group was significantly better than the control group (P<0.05).After anti infection scheme adjustment,there were no statistically significant differences in the treatment effect and mortality between the two groups(P>0.05),and the treatment effect of control group was significantly better than before the adjustment(P<0.05).Conclusion:Carrying out the investigation of mixed infection of atypical pathogenic bacteria in patients with COPD,can improve the treatment effect of the patients.